↓ Skip to main content

Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data

Overview of attention for article published in PLOS ONE, April 2012
Altmetric Badge

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
62 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
Published in
PLOS ONE, April 2012
DOI 10.1371/journal.pone.0035298
Pubmed ID
Authors

Alexander Tenenbaum, Diego Medvedofsky, Enrique Z. Fisman, Liudmila Bubyr, Shlomi Matetzky, David Tanne, Robert Klempfner, Joseph Shemesh, Ilan Goldenberg

Abstract

The effect of combination of fibrate with statin on major adverse cardiovascular events (MACE) following acute coronary syndrome (ACS) hospitalization is unclear. The main aim of this study was to investigate the 30-day rate of MACE in patients who participated in the nationwide ACS Israeli Surveys (ACSIS) and were treated on discharge with a fibrate (mainly bezafibrate) and statin combination vs. statin alone.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
United Kingdom 1 2%
Unknown 60 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 16%
Other 8 13%
Student > Master 8 13%
Student > Bachelor 6 10%
Researcher 4 6%
Other 13 21%
Unknown 13 21%
Readers by discipline Count As %
Medicine and Dentistry 29 47%
Nursing and Health Professions 7 11%
Unspecified 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Psychology 2 3%
Other 5 8%
Unknown 15 24%